Regulatory News
Friday, March 18, 2016
UPDATE 2-U.S. FDA rejects Eagle Pharma's blood thinner
* Shares fall as much as 22 pct
(Adds analysts comments, updates shares)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment